Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PTC Therapeutics Inc.

www.ptcbio.com

Latest From PTC Therapeutics Inc.

Novartis's Gene Therapy Zolgensma Has Durable Effects At Five Years

AveXis/Novartis’s one-time AAV9 vector-based intravenous gene therapy for spinal muscular atrophy, Zolgensma, continues to have beneficial effects up to five years after its administration to babies, and an intrathecal formulation has significant promise in older infants.

Gene Therapy Clinical Trials

Potential Cardiovascular Blockbuster Inclisiran Among New Filings At EMA

The European Medicines Agency has agreed to review pan-EU marketing applications for a number of new medicines.

Europe Approvals

Long Hot Summer For Novel Drug Reviews Forecast At US FDA

Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.

Approvals Drug Review

Patent Settlements May Break EU Law

Patent-litigation settlements reached almost 20 years ago in the UK over GSK’s Seroxat paroxetine antidepressant may contravene EU competition law, an advocate general has advised the CJEU.

Intellectual Property Legal Issues
See All

Company Information

  • Industry
  • Biotechnology
    • Antisense, Oligonucleotides
    • Drug Discovery Tools
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Infectious & Viral Diseases
  • Musculoskeletal & Connective Tissue Disorders
  • Neurology, Nervous System
  • Respiratory, Pulmonary
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • PTC Therapeutics Inc.
  • Senior Management
  • Stuart W Peltz, PhD, CEO
    Emily Hill, CFO
    Mark J Pykett, PhD, CSO
    Megan Sniecinski , SVP, Bus. Operations & Program Mgmt.
    Marcio Souza, COO
  • Contact Info
  • PTC Therapeutics Inc.
    Phone: (908) 222-7000
    100 Corporate Ct.
    South Plainfield, NJ 07080-2449
    USA
UsernamePublicRestriction

Register